Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000825666 | SCV000967065 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Ala1078Thr in exon 35 of COL4A4: This variant is not expected to have clinical significance because it has been identified in 1.85% (177/9562) of African chro mosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.or g; dbSNP rs77277077). |
Gene |
RCV000844406 | SCV000986457 | benign | not provided | 2018-04-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000844406 | SCV001105461 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000825666 | SCV001474846 | benign | not specified | 2020-07-09 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002294385 | SCV002587395 | benign | Kidney disorder | 2018-05-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000844406 | SCV004151532 | benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | COL4A4: BS1, BS2 |
Natera, |
RCV001271503 | SCV001452710 | benign | Alport syndrome | 2020-01-05 | no assertion criteria provided | clinical testing |